Stem Cell Research
Investigators from Catholic University of Korea Publish New Data on Stem Cell Research
Published in Blood Weekly, January 5th, 2012
2012 JAN 5 -- According to the authors of a study from Seoul, South Korea, "The aim of this study was to determine the optimum conditioning intensity for allogeneic stem cell transplantation (SCT) in young (age =50), lower-risk (INT-1 by IPSS) Myelodysplastic syndrome (MDS) patients without significant comorbidities (hematopoietic cell transplantation-comorbidity index score =3). Transplant outcomes from 46 consecutive patients were retrospectively analyzed according to the conditioning intensity: reduced-intensity conditioning (RIC; n = 14), intensified RIC by adding low-dose total body irradiation (iRIC; n = 15), and myeloablative conditioning (MAC; n = 17)."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2012-01-05)
More Articles from Blood Weekly
- Intranuclear Space
Data on Intranuclear Space Discussed by Researchers at North Carolina State University - Blood Research
Findings from Shanghai University in Blood Research Reported - Health Care, Hospitals
In one year alone - A significant drop in the wait time for corneal transplants - Sepsis
Investigators from Huazhong University Zero in on Sepsis - Sepsis
New Sepsis Research Reported from University of Pittsburgh - Lung Transplantation
Reports Summarize Lung Transplantation Study Results from Alfred Hospital - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
